Overview

Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Phase III two arm double-blinded randomised controlled trial to examine the effect of prophylactic low-dose aspirin from the first-trimester of pregnancy in women at increased risk for PET on the incidence and severity of the disease
Phase:
Phase 3
Details
Lead Sponsor:
Rabin Medical Center
Collaborator:
University College, London
Treatments:
Aspirin